New Horizon Health HK$2.04 billion IPO
We advised New Horizon Health on its IPO and HKEX listing
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Akeso HK$1.19 billion share placement
We advised the placing agent in the placement of new shares
UP Fintech $65 million convertible notes private placement
We are advising UP Fintech, a Nasdaq-listed online brokerage firm, on its private placement of convertible notes
Youdao $238 million equity follow-on offering
We advised Youdao on its offering of ADSs
Adagene $161 million IPO
We advised Adagene on its IPO and Nasdaq listing
China SCE $350 million high-yield notes offering
We advised the initial purchasers on the Regulation S senior notes offering
Hopson Development $100 million high-yield notes reopening
We advised the initial purchasers on the Regulation S senior notes offering
Ocumension Therapeutics HK$793.8 million top-up placement of shares
We advised the placing agent in connection with the equity offering
Ronshine China Holdings $200 million high-yield notes offering
We advised the initial purchasers on the Regulation S offering
Venus Medtech HK$1.4 billion placing of new H shares
We advised Venus Medtech (Hangzhou) on its placement of new shares